ISSN 1016-5169 | E-ISSN 1308-4488
pdf
Statins in primary and secondary prevention: what should the target LDL cholesterol value be? [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 2006; 34(4): 246-254

Statins in primary and secondary prevention: what should the target LDL cholesterol value be?

Turgay Çelik, Uygar Çağdaş Yüksel, Ersoy Işık
Gülhane Askeri Tıp Akademisi Kardiyoloji Anabilim Dalı, Ankara

Lowering low-density lipoprotein (LDL) cholesterol levels is among the most important issues in combatting with atherosclerotic diseases. Introduction of statins has launched a new era in this field. Trials conducted in the past 20 years have shown the effect of statins on improved survival, with accumulating evidence justifying the need for lowering the limits set for LDL cholesterol levels. In this review, target LDL cholesterol levels pertaining to statin use are discussed in different risk groups in view of relevant randomized controlled trials.

Keywords: Anticholesteremic agents/therapeutic use; cardiovascular diseases/prevention & control; hypercholesterolemia; lipoproteins, LDL cholesterol; myocardial infarction/drug therapy.

How to cite this article
Turgay Çelik, Uygar Çağdaş Yüksel, Ersoy Işık. Statins in primary and secondary prevention: what should the target LDL cholesterol value be?. Turk Kardiyol Dern Ars. 2006; 34(4): 246-254

Corresponding Author: Turgay Çelik, Türkiye
Manuscript Language: Turkish


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search



Copyright © 2024 Archives of the Turkish Society of Cardiology



Kare Publishing is a subsidiary of Kare Media.